BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37082926)

  • 21. Rhabdomyosarcoma With
    Ishiyama T; Kato I; Ito J; Matsumura M; Saito K; Kawabata Y; Kato S; Takeyama M; Fujii S
    Int J Surg Pathol; 2023 Aug; 31(5):805-812. PubMed ID: 36437645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelioid and spindle cell rhabdomyosarcoma with EWSR1::TFCP2 fusion mimicking metastatic lung cancer: A case report and literature review.
    Haug L; Doll J; Appenzeller S; Kunzmann V; Rosenwald A; Maurus K; Gerhard-Hartmann E
    Pathol Res Pract; 2023 Sep; 249():154779. PubMed ID: 37633005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas.
    Panferova A; Sinichenkova KY; Abu Jabal M; Usman N; Sharlai A; Roshchin V; Konovalov D; Druy A
    Cold Spring Harb Mol Case Stud; 2022 Jun; 8(5):. PubMed ID: 35768243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens.
    Montoya-Cerrillo DM; Diaz-Perez JA; Velez-Torres JM; Montgomery EA; Rosenberg AE
    Genes Chromosomes Cancer; 2021 Oct; 60(10):687-694. PubMed ID: 34184341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Rare Case Report of Intraosseous Spindle and Epithelioid Rhabdomyosarcoma With
    Si C; Wang Y; Zhu J
    Int J Surg Pathol; 2024 Mar; ():10668969241239676. PubMed ID: 38500382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
    Dehner CA; Broski SM; Meis JM; Murugan P; Chrisinger JSA; Sosa C; Petersen M; Halling KC; Gupta S; Folpe AL
    Mod Pathol; 2023 Oct; 36(10):100271. PubMed ID: 37422156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelioid and Spindle Cell Rhabdomyosarcoma of the Oral Mucosa with FUS Rearrangement.
    Ochsner AR; Foss RD
    Head Neck Pathol; 2022 Sep; 16(3):823-827. PubMed ID: 35353344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular profile of head and neck rhabdomyosarcomas: A systematic review and meta-analysis.
    Gallagher KPD; van Heerden W; Said-Al-Naief N; Carlos R; Arboleda LPA; Rodrigues-Fernandes CI; Araújo ALD; Fonseca FP; Pontes HAR; Innocentini LMAR; Romañach MJ; Vargas PA; Lopes MA; Santos-Silva AR; Khurram SA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Sep; 134(3):354-366. PubMed ID: 35840496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spindle Cell/Sclerosing Rhabdomyosarcoma With
    Rakheja D; Park JY; Alhasan M; Uddin N
    Int J Surg Pathol; 2022 Dec; 30(8):950-955. PubMed ID: 35466752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.
    El Zein S; Djeroudi L; Reynaud S; Guillemot D; Masliah-Planchon J; Frouin E; Nicolas N; Le Loarer F; Daniel C; Delattre O; Pierron G; Watson S
    Genes Chromosomes Cancer; 2022 Apr; 61(4):200-205. PubMed ID: 34877752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript.
    Brunac AC; Laprie A; Castex MP; Laurent C; Le Loarer F; Karanian M; Le Guellec S; Guillemot D; Pierron G; Gomez-Brouchet A
    Pediatr Blood Cancer; 2020 May; 67(5):e28185. PubMed ID: 31965718
    [No Abstract]   [Full Text] [Related]  

  • 35. Mandibular rhabdomyosarcoma with TFCP2 rearrangement and osteogenic differentiation: a case misdiagnosed as fibrous dysplasia or low-grade central osteosarcoma.
    Chen F; Wang J; Sun Y; Zhang J
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jan; ():. PubMed ID: 38637236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current landscape of rhabdomyosarcomas: an update.
    Leiner J; Le Loarer F
    Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022. Emerging Bone and Soft Tissue Neoplasms in the Head and Neck Region.
    Xu B
    Head Neck Pathol; 2022 Mar; 16(1):158-167. PubMed ID: 35307771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
    Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
    Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathological features of rhabdomyosarcoma with TFCP2 fusions].
    Chen XY; Chen G; Zhu Q; Zhu WF; He C; Huang RF
    Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):545-547. PubMed ID: 35673728
    [No Abstract]   [Full Text] [Related]  

  • 40. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.